These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32064780)

  • 1. Outcome in German and South African peripartum cardiomyopathy cohorts associates with medical therapy and fibrosis markers.
    Azibani F; Pfeffer TJ; Ricke-Hoch M; Dowling W; Pietzsch S; Briton O; Baard J; Abou Moulig V; König T; Berliner D; Libhaber E; Schlothauer S; Anthony J; Lichtinghagen R; Bauersachs J; Sliwa K; Hilfiker-Kleiner D
    ESC Heart Fail; 2020 Apr; 7(2):512-522. PubMed ID: 32064780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy.
    Hilfiker-Kleiner D; Haghikia A; Masuko D; Nonhoff J; Held D; Libhaber E; Petrie MC; Walker NL; Podewski E; Berliner D; Bauersachs J; Sliwa K
    Eur J Heart Fail; 2017 Dec; 19(12):1723-1728. PubMed ID: 28345302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In peripartum cardiomyopathy plasminogen activator inhibitor-1 is a potential new biomarker with controversial roles.
    Ricke-Hoch M; Hoes MF; Pfeffer TJ; Schlothauer S; Nonhoff J; Haidari S; Bomer N; Scherr M; Stapel B; Stelling E; Kiyan Y; Falk C; Haghikia A; Binah O; Arany Z; Thum T; Bauersachs J; van der Meer P; Hilfiker-Kleiner D
    Cardiovasc Res; 2020 Sep; 116(11):1875-1886. PubMed ID: 31711127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up in peripartum cardiomyopathy patients with contemporary treatment: low mortality, high cardiac recovery, but significant cardiovascular co-morbidities.
    Moulig V; Pfeffer TJ; Ricke-Hoch M; Schlothauer S; Koenig T; Schwab J; Berliner D; Pfister R; Michels G; Haghikia A; Falk CS; Duncker D; Veltmann C; Hilfiker-Kleiner D; Bauersachs J
    Eur J Heart Fail; 2019 Dec; 21(12):1534-1542. PubMed ID: 31724271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction.
    Haghikia A; Schwab J; Vogel-Claussen J; Berliner D; Pfeffer T; König T; Zwadlo C; Moulig VA; Franke A; Schwarzkopf M; Ehlermann P; Pfister R; Michels G; Westenfeld R; Stangl V; Kühl U; Podewski E; Kindermann I; Böhm M; Sliwa K; Hilfiker-Kleiner D; Bauersachs J
    Clin Res Cardiol; 2019 Mar; 108(3):290-297. PubMed ID: 30121697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy.
    Haghikia A; Podewski E; Libhaber E; Labidi S; Fischer D; Roentgen P; Tsikas D; Jordan J; Lichtinghagen R; von Kaisenberg CS; Struman I; Bovy N; Sliwa K; Bauersachs J; Hilfiker-Kleiner D
    Basic Res Cardiol; 2013 Jul; 108(4):366. PubMed ID: 23812247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripartum cardiomyopathy in Iraq: initial registry-based data and 6 month outcomes.
    Farhan HA; Yaseen IF
    ESC Heart Fail; 2021 Oct; 8(5):4048-4054. PubMed ID: 34184413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.
    Haghikia A; Podewski E; Berliner D; Sonnenschein K; Fischer D; Angermann CE; Böhm M; Röntgen P; Bauersachs J; Hilfiker-Kleiner D
    Clin Res Cardiol; 2015 Nov; 104(11):911-7. PubMed ID: 26026286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO-HF retrospective cohort study.
    Tremblay-Gravel M; Marquis-Gravel G; Avram R; Desplantie O; Ducharme A; Bibas L; Pacheco C; Couture E; Simard F; Poulin A; Malhamé I; Tran D; Rey E; Tournoux F; Harvey L; Sénéchal M; Bélisle P; Descarries L; Farand P; Pranno N; Diaz A; Afilalo J; Ly HQ; Fortier A; Jolicoeur EM;
    ESC Heart Fail; 2019 Feb; 6(1):27-36. PubMed ID: 30565890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.
    Pfeffer TJ; Mueller JH; Haebel L; Erschow S; Yalman KC; Talbot SR; Koenig T; Berliner D; Zwadlo C; Scherr M; Hilfiker-Kleiner D; Bauersachs J; Ricke-Hoch M
    ESC Heart Fail; 2023 Feb; 10(1):465-477. PubMed ID: 36300679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study.
    Sliwa K; Blauwet L; Tibazarwa K; Libhaber E; Smedema JP; Becker A; McMurray J; Yamac H; Labidi S; Struman I; Hilfiker-Kleiner D
    Circulation; 2010 Apr; 121(13):1465-73. PubMed ID: 20308616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic Profiling in Patients With Peripartum Cardiomyopathy: A Biomarker Study of the ESC EORP PPCM Registry.
    Kodogo V; Viljoen C; Hoevelmann J; Chakafana G; Tromp J; Farhan HA; Goland S; van der Meer P; Karaye K; Kryczka K; Hilfiker-Kleiner D; Jackson A; Mebazaa A; Böhm M; Pieske B; Bauersachs J; Bell L; Sliwa K;
    JACC Heart Fail; 2023 Dec; 11(12):1708-1725. PubMed ID: 37804308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry.
    Jackson AM; Petrie MC; Frogoudaki A; Laroche C; Gustafsson F; Ibrahim B; Mebazaa A; Johnson MR; Seferovic PM; Regitz-Zagrosek V; Mbakwem A; Böhm M; Prameswari HS; Fouad DA; Goland S; Damasceno A; Karaye K; Farhan HA; Hamdan R; Maggioni AP; Sliwa K; Bauersachs J; van der Meer P;
    Eur J Heart Fail; 2021 Dec; 23(12):2058-2069. PubMed ID: 34114268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study.
    Hilfiker-Kleiner D; Haghikia A; Berliner D; Vogel-Claussen J; Schwab J; Franke A; Schwarzkopf M; Ehlermann P; Pfister R; Michels G; Westenfeld R; Stangl V; Kindermann I; Kühl U; Angermann CE; Schlitt A; Fischer D; Podewski E; Böhm M; Sliwa K; Bauersachs J
    Eur Heart J; 2017 Sep; 38(35):2671-2679. PubMed ID: 28934837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting poor left ventricular function recovery in Peripartum cardiomyopathy.
    Prameswari HS; Iswandi CP; Hasan M; Martanto E; Putra ICS; Kamarullah W; Dewi TI; Akbar MR
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2279018. PubMed ID: 37935592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of Early Diagnosis in Peripartum Cardiomyopathy.
    Lewey J; Levine LD; Elovitz MA; Irizarry OC; Arany Z
    Hypertension; 2020 Jan; 75(1):91-97. PubMed ID: 31707840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel score to predict left ventricular recovery in peripartum cardiomyopathy derived from the ESC EORP Peripartum Cardiomyopathy Registry.
    Jackson AM; Goland S; Farhan HA; Yaseen IF; Prameswari HS; Böhm M; Jhund PS; Maggioni AP; van der Meer P; Sliwa K; Bauersachs J; Petrie MC
    Eur Heart J; 2024 Apr; 45(16):1430-1439. PubMed ID: 38282532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy.
    Goland S; Bitar F; Modi K; Safirstein J; Ro A; Mirocha J; Khatri N; Elkayam U
    J Card Fail; 2011 May; 17(5):426-30. PubMed ID: 21549301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of bromocriptine in peripartum cardiomyopathy: a systematic review and meta-analysis.
    Trongtorsak A; Kittipibul V; Mahabir S; Ibrahim M; Saint Croix GR; Hernandez GA; Chaparro S
    Heart Fail Rev; 2022 Mar; 27(2):533-543. PubMed ID: 34725781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry.
    Sliwa K; Petrie MC; van der Meer P; Mebazaa A; Hilfiker-Kleiner D; Jackson AM; Maggioni AP; Laroche C; Regitz-Zagrosek V; Schaufelberger M; Tavazzi L; Roos-Hesselink JW; Seferovic P; van Spaendonck-Zwarts K; Mbakwem A; Böhm M; Mouquet F; Pieske B; Johnson MR; Hamdan R; Ponikowski P; Van Veldhuisen DJ; McMurray JJV; Bauersachs J
    Eur Heart J; 2020 Oct; 41(39):3787-3797. PubMed ID: 32840318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.